Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery (FCAD02)

This study has been completed.
Information provided by (Responsible Party):
Pfizer Identifier:
First received: February 5, 2009
Last updated: February 2, 2012
Last verified: February 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 27, 2012